Horacio J Asbun1, Alma L Moekotte2,3, Frederique L Vissers3, Filipe Kunzler1, Federica Cipriani4, Adnan Alseidi5, Michael I D'Angelica6, Alberto Balduzzi7, Claudio Bassi7, Bergthor Björnsson8, Ugo Boggi9, Mark P Callery10, Marco Del Chiaro11, Felipe J Coimbra12, Claudius Conrad13, Andrew Cook14, Alessandro Coppola15, Christos Dervenis16, Safi Dokmak17, Barish H Edil18, Bjørn Edwin19, Pier C Giulianotti20, Ho-Seong Han21, Paul D Hansen22, Nicky van der Heijde2,3, Jony van Hilst3, Caitlin A Hester23, Melissa E Hogg24, Nicolas Jarufe25, D Rohan Jeyarajah26, Tobias Keck27, Song Cheol Kim28, Igor E Khatkov29, Norihiro Kokudo30, David A Kooby31, Maarten Korrel3, Francisco J de Leon32, Nuria Lluis33, Sanne Lof2,3, Marcel A Machado34, Nicolas Demartines35, John B Martinie36, Nipun B Merchant37, I Quintus Molenaar38, Cassadie Moravek39, Yi-Ping Mou40, Masafumi Nakamura41, William H Nealon42, Chinnusamy Palanivelu43, Patrick Pessaux44, Henry A Pitt45, Patricio M Polanco23, John N Primrose2, Arab Rawashdeh2, Dominic E Sanford46, Palanisamy Senthilnathan43, Shailesh V Shrikhande47, John A Stauffer48, Kyoichi Takaori49, Mark S Talamonti24, Chung N Tang50, Charles M Vollmer51, Go Wakabayashi52, R Matthew Walsh53, Shin-E Wang54, Michael J Zinner1, Christopher L Wolfgang55, Amer H Zureikat56, Maurice J Zwart3, Kevin C Conlon57, Michael L Kendrick58, Herbert J Zeh56, Mohammad Abu Hilal2,59, Marc G Besselink3. 1. Division of Hepatobiliary and Pancreas Surgery, Miami Cancer Institute, Miami, FL. 2. Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK. 3. Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. 4. Department of Surgery, San Raffaele Hospital, Milan, Italy. 5. Division of Hepatopancreatobiliary and Endocrine Surgery, Virginia Mason Medical Center, Seattle, VA. 6. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY. 7. Division of Pancreatic Surgery, University Hospital of Verona, Verona, Italy. 8. Department of Surgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. 9. Division of General and Transplant Surgery, University of Pisa, Pisa, Italy. 10. Department of General and Gastrointestinal Surgery, Beth Israel Deaconess Medical Center, Boston, MA. 11. Department of Surgery, Division of Surgical Oncology, University of Colorado, Denver, CO. 12. Department of Abdominal Surgery, AC Camargo Cancer Center, São Paulo, Brazil. 13. Department of Surgery, St. Elizabeth's Medical Center, Boston, MA. 14. Wessex Institute, University of Southampton, UK. 15. General Surgery and Liver Transplant, Unit Department of General Surgery, Fondazione Policlinico, Universitario Agostino Gemelli, IRCCS, Rome, Italy. 16. Department of Surgery, Medical School, University of Cyprus, Cyprus. 17. Department of Surgery, Beaujon Hospital, Paris, France. 18. Department of Surgery, University of Oklahoma, Oklahoma City, OK. 19. The Intervention Centre and Department of HPB Surgery, Oslo University Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. 20. Division of Minimally Invasive, General Surgery & Robotic Surgery, University of Illinois, Chicago, IL. 21. Department of Surgery, Seoul National University Hospital, Seoul, South Korea. 22. Department of Surgery, Portland Providence Medical Center, Portland, OR. 23. Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX. 24. Department of Surgery, NorthShore University Health System, Evanston, IL. 25. Department of Digestive Surgery, Pontifical Catholic University of Chile, Santiago, Chile. 26. Department of HPB surgery, Methodist Richardson Medical Center, Richardson, TX. 27. Clinic for Surgery, University of Schleswig-Holstein Campus Lübeck, Lübeck, Germany. 28. Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, South Korea. 29. Department of Surgery, Moscow Clinical Scientific Center, Moscow, Russia. 30. Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan. 31. Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA. 32. HPB and transplant Unit, Regional Hospital, Málaga, Spain. 33. Department of Surgery, Bellvitge University Hospital, Barcelona, Spain. 34. Department of Surgery, University of São Paulo, São Paulo, Brazil. 35. Department of Visceral Surgery, Lausanne University Hospital CHUV, Lausanne, Switzerland. 36. Division of HPB Surgery, Department of Surgery, Carolina's Health Care Hospital, Charlotte, NC. 37. Division of Surgical Oncology, Department of Surgery, University of Miami Miller School of Medicine, Miami, FL. 38. Department of Surgery, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, the Netherlands. 39. Pancreatic Cancer Action Network, Manhattan Beach, CA. 40. Department of Gastroenterology and Pancreatic surgery, Zhengjiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Zhejiang, China. 41. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. 42. Department of Surgery, Northwell Health, Manhasset, NY. 43. Department of Surgical Gastroenterology and HPB Surgery, GEM Hospital and Research Centre, Coimbatore, Tamil Nadu, India. 44. Division of Hepato-Biliary and Pancreatic Surgery, Nouvel Hôpital Civil, Institut Hospitalo-Universitaire de Strasbourg, Strasbourg, France. 45. Department of Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA. 46. Division of Hepatobiliary, Pancreatic, and Gastrointestinal Surgery, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO. 47. Department of Surgery, Tata Memorial Center, Mumbai, India. 48. Department of General Surgery, Mayo Clinic Florida, Jacksonville, FL. 49. Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan. 50. Department of Surgery, Pamela Youde Nethersle Eastern Hospital, Chai Wan, Hong Kong, China. 51. Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 52. Center for Advanced Treatment of HPB Diseases, Ageo Central General Hospital, Saitama, Japan. 53. Department of General Surgery, Cleveland Clinic, Cleveland, OH. 54. Department of Surgery, Taipei Veterans General Hospital and National Yang Ming University, Taipei, Taiwan. 55. Division of Surgical Oncology, Department of Surgery, The John Hopkins University School of Medicine, Baltimore, MD. 56. Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA. 57. Department of Surgery, Trinity College Dublin, Tallaght University Hospital, Dublin, Ireland. 58. Department of Surgery, Mayo Clinic, Rochester, Minnesota, MN. 59. Department of Surgery, Istituto Fondazione Poliambulanza, Brescia, Italy.
Abstract
OBJECTIVE: The aim of this study was to develop and externally validate the first evidence-based guidelines on minimally invasive pancreas resection (MIPR) before and during the International Evidence-based Guidelines on Minimally Invasive Pancreas Resection (IG-MIPR) meeting in Miami (March 2019). SUMMARY BACKGROUND DATA: MIPR has seen rapid development in the past decade. Promising outcomes have been reported by early adopters from high-volume centers. Subsequently, multicenter series as well as randomized controlled trials were reported; however, guidelines for clinical practice were lacking. METHODS: The Scottisch Intercollegiate Guidelines Network (SIGN) methodology was used, incorporating these 4 items: systematic reviews using PubMed, Embase, and Cochrane databases to answer clinical questions, whenever possible in PICO style, the GRADE approach for assessment of the quality of evidence, the Delphi method for establishing consensus on the developed recommendations, and the AGREE-II instrument for the assessment of guideline quality and external validation. The current guidelines are cosponsored by the International Hepato-Pancreato-Biliary Association, the Americas Hepato-Pancreato-Biliary Association, the Asian-Pacific Hepato-Pancreato-Biliary Association, the European-African Hepato-Pancreato-Biliary Association, the European Association for Endoscopic Surgery, Pancreas Club, the Society of American Gastrointestinal and Endoscopic Surgery, the Society for Surgery of the Alimentary Tract, and the Society of Surgical Oncology. RESULTS: After screening 16,069 titles, 694 studies were reviewed, and 291 were included. The final 28 recommendations covered 6 topics; laparoscopic and robotic distal pancreatectomy, central pancreatectomy, pancreatoduodenectomy, as well as patient selection, training, learning curve, and minimal annual center volume required to obtain optimal outcomes and patient safety. CONCLUSION: The IG-MIPR using SIGN methodology give guidance to surgeons, hospital administrators, patients, and medical societies on the use and outcome of MIPR as well as the approach to be taken regarding this challenging type of surgery.
OBJECTIVE: The aim of this study was to develop and externally validate the first evidence-based guidelines on minimally invasive pancreas resection (MIPR) before and during the International Evidence-based Guidelines on Minimally Invasive Pancreas Resection (IG-MIPR) meeting in Miami (March 2019). SUMMARY BACKGROUND DATA: MIPR has seen rapid development in the past decade. Promising outcomes have been reported by early adopters from high-volume centers. Subsequently, multicenter series as well as randomized controlled trials were reported; however, guidelines for clinical practice were lacking. METHODS: The Scottisch Intercollegiate Guidelines Network (SIGN) methodology was used, incorporating these 4 items: systematic reviews using PubMed, Embase, and Cochrane databases to answer clinical questions, whenever possible in PICO style, the GRADE approach for assessment of the quality of evidence, the Delphi method for establishing consensus on the developed recommendations, and the AGREE-II instrument for the assessment of guideline quality and external validation. The current guidelines are cosponsored by the International Hepato-Pancreato-Biliary Association, the Americas Hepato-Pancreato-Biliary Association, the Asian-Pacific Hepato-Pancreato-Biliary Association, the European-African Hepato-Pancreato-Biliary Association, the European Association for Endoscopic Surgery, Pancreas Club, the Society of American Gastrointestinal and Endoscopic Surgery, the Society for Surgery of the Alimentary Tract, and the Society of Surgical Oncology. RESULTS: After screening 16,069 titles, 694 studies were reviewed, and 291 were included. The final 28 recommendations covered 6 topics; laparoscopic and robotic distal pancreatectomy, central pancreatectomy, pancreatoduodenectomy, as well as patient selection, training, learning curve, and minimal annual center volume required to obtain optimal outcomes and patient safety. CONCLUSION: The IG-MIPR using SIGN methodology give guidance to surgeons, hospital administrators, patients, and medical societies on the use and outcome of MIPR as well as the approach to be taken regarding this challenging type of surgery.
Authors: Andrew A Gumbs; Elie Chouillard; Mohamed Abu Hilal; Roland Croner; Brice Gayet; Michel Gagner Journal: Surg Endosc Date: 2020-11-04 Impact factor: 4.584
Authors: A Balduzzi; N van der Heijde; A Alseidi; S Dokmak; M L Kendrick; P M Polanco; D E Sandford; S V Shrikhande; C M Vollmer; S E Wang; H J Zeh; M Abu Hilal; H J Asbun; M G Besselink Journal: Langenbecks Arch Surg Date: 2020-12-10 Impact factor: 3.445
Authors: Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker Journal: Endocr Rev Date: 2021-03-15 Impact factor: 19.871